Search Result "HER2 status"
MicroRNA and HER2-overexpressing Cancer
Journal: MicroRNA
Volume: 2 Issue: 2 Year: 2013 Page: 137-147
Author(s): Shizhen E. Wang,Ren-Jang Lin
Anti-HER2 Cancer Therapy and Cardiotoxicity
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 4911-4919
Author(s): Tania Babar, Christopher Blomberg, Eileen Hoffner, Xinhua Yan
Personalizing HER2-Targeted Therapy in Metastatic Breast Cancer Beyond HER2 Status: What We Have Learned from Clinical Specimens
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 7 Issue: 4 Year: 2009 Page: 263-274
Author(s): R. Nahta, S. Shabaya, T. Ozbay, D. L. Rowe
Autophagy-related Prognostic Signature in HER2 Positive GastricCarcinomas
Journal: Current Molecular Medicine
Volume: 22 Issue: 9 Year: 2022 Page: 809-818
Author(s): Giovanni Tuccari,Rosario Alberto Caruso,Giuseppe Giuffrè,Cristina Pizzimenti,Antonio Ieni
Neoadjuvant Therapy for HER2-positive Breast Cancer
Journal: Reviews on Recent Clinical Trials
Volume: 12 Issue: 2 Year: 2017 Page: 81-92
Author(s): Rachel Wuerstlein,Nadia Harbeck
HER2 Targeted Therapies for Cancer and the Gastrointestinal Tract
Journal: Current Drug Targets
Volume: 10 Issue: 6 Year: 2009 Page: 537-542
Author(s): Noor Al-Dasooqi, Rachel Gibson, Joanne Bowen, Dorothy Keefe
A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 8 Year: 2015 Page: 665-683
Author(s): OtÃlia Menyhart,Libero Santarpia,Balazs Gyorffy
P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 4 Year: 2014 Page: 501-510
Author(s): S.M. Donnelly, E. Paplomata, B.M. Peake, E. Sanabria, Z. Chen, R. Nahta
HER2 Targeted Monoclonal Antibodies and Tyrosine Kinase Inhibitors
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 4 Year: 2014
Author(s): Neil A. O`Brien,Alexandra Canonici,Karen Howe,Martina S.J. McDermott,Denis M. Collins,Brigid C. Browne,John Crown,Norma O`Donovan
Doi: 10.2174/978160859225114040007
Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy
Journal: Current Cancer Drug Targets
Volume: 17 Issue: 4 Year: 2017 Page: 344-356
Author(s): Heena Singla,Sourav Kalra,Preeti Kheterpal,Vinod Kumar,Anjana Munshi